Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quorum Sensing Signal Molecules (QSSMs) and Immune Dysfunction in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) for Obstructive Jaundice

NCT01367821 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT01367821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01367821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quorum Sensing Signal Molecules (QSSMs) and Immune Dysfunction in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) for Obstructive Jaundice
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2011
Completion date
December 31, 2012
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease as reason for ercp, immune dysfunction, immune tolerance, obstructive jaundice